FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.
What happened
In September 2026, FDA reviewed New Green Nutrition’s website and obtained a sample of “Qu Feng Huo Luo Dan” through the site. Laboratory analysis confirmed the product contains dexamethasone, a steroid not declared on the label. FDA also found disease-treatment claims for four products, making them unapproved new drugs.
What FDA found
The website and packaging label four products for treating diseases, so FDA treats them as drugs.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)FDA says the four products are unapproved new drugs because no FDA-approved application is in effect for them.
FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)Qu Feng Huo Luo Dan is misbranded because its label does not disclose dexamethasone, which FDA lab analysis found in the product.
FD&C Act section 502(a), 21 U.S.C. 352(a)
What FDA wants
FDA tells the company to respond within 15 business days to FDAAdvisory@fda.hhs.gov with the corrective steps taken, steps to prevent recurrence, and related documents, and to include reference number 737576 in the subject line.
Who should pay attention
- retailers and online marketplaces selling imported herbal products
- consumers using arthritis, pain, or eye products
- brands that depend on accurate ingredient labels
This is a summary. Read the original letter on fda.gov.